These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16584523)

  • 21. Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration.
    Bonnema SJ; Nielsen VE; Boel-Jørgensen H; Grupe P; Andersen PB; Bastholt L; Hegedüs L
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3981-4. PubMed ID: 18664541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human thyrotropin stimulation prior to
    Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
    Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters.
    Duick DS; Baskin HJ
    Endocr Pract; 2003; 9(3):204-9. PubMed ID: 12917062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.
    Graf H; Fast S; Pacini F; Pinchera A; Leung A; Vaisman M; Reiners C; Wemeau JL; Huysmans D; Harper W; Driedger A; de Souza HN; Castagna MG; Antonangeli L; Braverman L; Corbo R; Düren C; Proust-Lemoine E; Edelbroek MA; Marriott C; Rachinsky I; Grupe P; Watt T; Magner J; Hegedus L
    J Clin Endocrinol Metab; 2011 May; 96(5):1368-76. PubMed ID: 21346067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter.
    Medeiros-Neto G; Marui S; Knobel M
    Endocrine; 2008 Apr; 33(2):109-17. PubMed ID: 18491237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffuse nontoxic and multinodular goiter.
    Nakhjavani M; Gharib H
    Curr Ther Endocrinol Metab; 1997; 6():109-12. PubMed ID: 9174716
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.
    Giusti M; Caorsi V; Mortara L; Caputo M; Monti E; Schiavo M; Bagnara MC; Minuto F; Bagnasco M
    Endocrine; 2014 Mar; 45(2):221-9. PubMed ID: 23619962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine.
    Albino CC; Mesa CO; Olandoski M; Ueda CE; Woellner LC; Goedert CA; Souza AM; Graf H
    J Clin Endocrinol Metab; 2005 May; 90(5):2775-80. PubMed ID: 15713700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.
    Fast S; Nielsen VE; Grupe P; Boel-Jørgensen H; Bastholt L; Andersen PB; Bonnema SJ; Hegedüs L
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2653-60. PubMed ID: 22577172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer.
    Schlumberger M; Ricard M; De Pouvourville G; Pacini F
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):641-50. PubMed ID: 17710085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishing and Monitoring an Effective Management of Benign Nontoxic Multinodular Goitre in Kuwait "Utilizing Two Different Dose Levels of Recombinant Human TSH in Combination with Radioactive Iodine".
    Al-Shammeri I; Masoomi M; Al-Shammeri N; Al-Abdali F; Al-Shagooli A
    Gulf J Oncolog; 2024 May; 1(45):49-63. PubMed ID: 38774933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine treatment for nontoxic multinodular goiter.
    Maurer AH; Charkes ND
    J Nucl Med; 1999 Aug; 40(8):1313-6. PubMed ID: 10450683
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioiodine therapy of non-toxic multinodular goitre.
    Glinoer D
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):713-4. PubMed ID: 7889604
    [No Abstract]   [Full Text] [Related]  

  • 34. Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay.
    Hovens GC; Heemstra KA; Buiting AM; Stokkel MP; Karperien M; Ballieux BE; Pereira AM; Romijn JA; Smit JW
    Nucl Med Commun; 2007 Feb; 28(2):123-7. PubMed ID: 17198353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Approach to management of the patient with primary or secondary intrathoracic goiter.
    Hegedüs L; Bonnema SJ
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5155-62. PubMed ID: 21131536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtle changes in serum thyrotrophin (TSH) and sex-hormone-binding globulin (SHBG) levels during long-term follow-up after radioactive iodine in multinodular non-toxic goitre.
    Jarløv AE; Faber J; Hegedüs L; Hansen JM
    Clin Endocrinol (Oxf); 1992 Oct; 37(4):335-7. PubMed ID: 1483288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum TSH and the response to radioiodine treatment of toxic multinodular goitre.
    Pedersen-Bjergaard U; Kirkegaard C
    Eur J Endocrinol; 1997 Oct; 137(4):365-9. PubMed ID: 9368504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodine treatment for benign thyroid diseases.
    Weetman AP
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):757-64. PubMed ID: 17466000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing the efficacy of
    Szumowski P; Abdelrazek S; Sykała M; Mojsak M; Żukowski Ł; Siewko K; Maliszewska K; Adamska A; Popławska-Kita A; Krętowski A; Myśliwiec J
    Endocrine; 2020 Jan; 67(1):136-142. PubMed ID: 31586293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of radioiodine induced Graves' disease in patients with multinodular toxic goiter.
    Meller J; Siefker U; Hamann A; Hüfner M
    Exp Clin Endocrinol Diabetes; 2006 May; 114(5):235-9. PubMed ID: 16804797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.